Diagnos Laboratorium Utama Tbk. vs Putra Rajawali Kencana Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 103.9K 24h volume), while Putra Rajawali Kencana Tbk. trades at Rp30 (market cap 195.36B, 1.12M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Putra Rajawali Kencana Tbk. is more actively traded (1.12M versus 103.9K). Which is the better fit depends on your goals.
| DGNS | PURA | |
|---|---|---|
Market Cap | 308B | 195.36B |
Volume | 103.9K | 1.12M |
Lot | 1.04K | 11.2K |
Turnover | 23.04M | 34.24M |
Average Price | 221.79 | 30.59 |
Value | 23.04M | 34.24M |
Indicative Equilibrium Price | 230 | 30 |
Indicative Equilibrium Volume | 110 | 1.61K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Putra Rajawali Kencana Tbk (the Company) was established based on notary deed No. 05 dated April 17, 2012 of Juanita Sari Dewi, SH., notary in Surabaya.
Read more on PURA →